The Puck Has Dropped For MSG Rangers

MSG Rangers Corporation is rated a cautious buy, trading near a 36% discount to estimated net asset value. MSGR's investment thesis centers on the rising valuation of scarce NHL franchises, with the Rangers valued at $4.15 billion. Control remains with James Dolan, limiting the likelihood of a near-term sale and potentially prolonging the valuation gap.

Seeking Alpha • 9 hours ago

MSG Rangers Corp. to Release Fiscal 2027 First Quarter Results

NEW YORK--(BUSINESS WIRE)--MSG Rangers Corp. (NYSE: MSGR) (“MSG Rangers”) will issue a press release on Friday, November 6, 2026 before the market opens reporting results for its fiscal first quarter ended September 30, 2026. This will mark the first quarter that MSG Rangers will report financial results as a standalone company, following its spin-off from MSG Knickerbockers Corp. (NYSE: MSGK), which was completed on October 26, 2026. About MSG Rangers Corp. MSG Rangers Corp. (MSG Rangers) is a.

Business Wire • Oct 30, 2026

MSG Rangers Becomes New Public Company

NEW YORK--(BUSINESS WIRE)--MSG Rangers Corp. (NYSE: MSGR) (the “Company” or “MSG Rangers”) announced that it has completed its spin-off from MSG Knickerbockers Corp. (NYSE: MSGK) (“MSG Knicks”), formerly Madison Square Garden Sports Corp., and will begin trading today on the NYSE under the ticker symbol “MSGR.” The spin-off distribution was completed at 11:59 p.m. ET on October 26, 2026 to stockholders of record of MSG Knicks as of the close of business on October 20, 2026. Each of MSG Knicks'.

Business Wire • Oct 27, 2026

Biotech & Crypto -- Best ETF Areas of Last Week

Biotech and cryptocurrency -- two ETF areas outperformed last week.

Zacks Investment Research • Aug 8, 2022

China ETFs Drop On Audit Enforcement

The first tranche of Chinese ADRs affected by a 2020 law has been released.

ETFcom • Mar 11, 2022

ETF Prime: Tom Hendrickson on Geopolitics & ETFs

On this week's episode of ETF Prime, host Nate Geraci is joined by Tom Hendrickson, president of ETF Trends and ETF Database, to discuss how recent geopolitical events are impacting the ETF world and investor behavior. Also joining the episode, Direxion's Dave Mazza offers his perspective on the current market environment and spotlights several thematic ETFs.

ETF Trends • Mar 2, 2022

Leveraged ETF: How to Use & What's Hot Now?

Geared funds are complex products; here is what you should know.

Zacks Investment Research • Feb 4, 2022

Direxion Launches mRNA Technology-Focused ETF

Direxion has announced today in a press release the launch of their newest ETF that focuses on the applications and developments of messenger RNA technology, the Direxion mRNA ETF (MSGR). The fund looks to capture the growth within the mRNA field by investing in companies that are working to develop and apply mRNA technology.

ETF Trends • Dec 9, 2021

Direxion Launches mRNA ETF (MSGR)

NEW YORK, Dec. 9, 2021 /PRNewswire/ --  Direxion announced today the launch of the Direxion mRNA ETF (Ticker: MSGR) . MSGR invests in companies believed to be at the forefront of the development and application of messenger RNA technology.

PRNewsWire • Dec 9, 2021